K70.9

Alcoholic liver disease, unspecified

Alcoholic liver disease (ALD) unspecified is a clinical designation used when a patient presents with clear evidence of liver injury attributable to excessive and chronic ethanol consumption, but the specific stage or morphological subtype (such as fatty liver, hepatitis, or cirrhosis) has not been pathologically or clinically isolated. ALD results from complex metabolic processes where ethanol metabolism produces toxic byproducts like acetaldehyde and highly reactive oxygen species. These substances induce oxidative stress, lipid peroxidation, and the recruitment of inflammatory cytokines, leading to hepatocyte damage and progressive fibrosis. Without intervention or cessation of alcohol intake, the condition frequently progresses through a spectrum of severity, potentially culminating in end-stage liver disease or hepatocellular carcinoma. This code is often utilized in acute or initial diagnostic settings before comprehensive imaging or biopsy has characterized the precise nature of the liver involvement.

Clinical Symptoms

  • Jaundice (icterus) of the skin and sclera
  • Right upper quadrant abdominal pain or tenderness
  • Hepatomegaly (enlarged liver)
  • Unexplained fatigue and malaise
  • Anorexia and unintended weight loss
  • Nausea and vomiting
  • Ascites (fluid accumulation in the peritoneal cavity)
  • Spider angiomata (vascular lesions on the skin)
  • Palmar erythema (reddening of the palms)
  • Peripheral edema (swelling of lower extremities)
  • Splenomegaly
  • Hepatic encephalopathy (confusion or altered consciousness)
  • Coagulopathy (easy bruising or bleeding)

Common Causes

  • Chronic excessive consumption of ethanol
  • Genetic predisposition (e.g., polymorphisms in the PNPLA3 or TM6SF2 genes)
  • Concomitant chronic viral hepatitis (specifically Hepatitis C)
  • Nutritional deficiencies (malnutrition common in chronic alcohol use)
  • Obesity and metabolic syndrome (synergistic hepatotoxicity)
  • Female sex (increased vulnerability to alcohol-induced liver injury at lower doses)
  • Iron overload (synergistic effect on oxidative stress)

Documentation & Coding Tips

Specify the clinical manifestation to avoid unspecified codes. When documentation supports a specific stage such as alcoholic fatty liver, alcoholic hepatitis, or alcoholic cirrhosis, use those specific codes instead of K70.9.

Example: Patient with chronic heavy alcohol use presents for follow-up. Evaluation shows hepatic steatosis on ultrasound and AST/ALT ratio of 2.1, confirming alcoholic fatty liver without hepatitis. Plan: Cessation counseling and repeat LFTs in 3 months. Note: Documentation of fatty liver (K70.0) provides higher specificity than K70.9, supporting accurate risk adjustment for chronic liver conditions.

Billing Focus: Specificity of manifestation and morphology.

Explicitly document the presence or absence of ascites. For alcoholic liver disease, the presence of ascites often triggers a more specific code and significantly increases the risk adjustment weight.

Example: Patient with alcoholic liver disease presents with increasing abdominal girth. Physical exam reveals a positive fluid wave and shifting dullness. Ultrasound confirms moderate ascites. This identifies the condition as alcoholic liver disease with ascites, potentially moving the diagnosis to K70.11 or K70.31 if hepatitis or cirrhosis is confirmed, which are high-weighted HCC categories.

Billing Focus: Complication status and presence of ascites.

Document the underlying alcohol use disorder (AUD) status. Link the liver disease to the patient's alcohol consumption habits, specifying if the use is abuse, dependence, or in remission.

Example: Patient has established alcoholic liver disease, currently unspecified (K70.9). Patient also meets criteria for alcohol dependence, currently in early partial remission (F10.21). Continued monitoring of liver enzymes required to assess for progression to cirrhosis. Documentation of the specific AUD status provides a clearer clinical picture for psychosocial risk factors.

Billing Focus: Co-morbidity linking and AUD specificity.

Utilize diagnostic findings to define the stage of fibrosis. If imaging or biopsy reports indicate fibrosis or sclerosis, document this explicitly to move from K70.9 to K70.2.

Example: Review of FibroScan results indicates a stiffness of 10.5 kPa, suggestive of F3 bridging fibrosis. Diagnosis updated from unspecified alcoholic liver disease to alcoholic fibrosis and sclerosis of liver (K70.2). This chronicity documentation ensures the severity of the liver damage is captured for long-term care planning.

Billing Focus: Diagnostic evidence of fibrosis or sclerosis.

Document the acuity of current symptoms to distinguish between chronic disease and acute alcoholic hepatitis. Acute presentations have different treatment protocols and coding requirements.

Example: Patient presents with acute onset jaundice, RUQ pain, and fever. Total bilirubin is 5.5 mg/dL. Clinical picture is consistent with acute alcoholic hepatitis (K70.10) rather than stable unspecified alcoholic liver disease. Patient is high risk for hepatic failure. This distinction is critical for capturing the acute severity and increased resource utilization during hospitalization.

Billing Focus: Acuity and clinical urgency.

Relevant CPT Codes

Related Diagnoses

Hierarchy